Inhibrx Biosciences, Inc. financial data

Symbol
INBX on Nasdaq
Location
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 469 %
Debt-to-equity 80.6 %
Return On Equity -138 % -109%
Return On Assets -76.3 %
Operating Margin -11.9K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares +0.07%
Common Stock, Shares, Outstanding 14.5M shares 0%
Entity Public Float 169M USD
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 15.5M shares +5.81%
Weighted Average Number of Shares Outstanding, Diluted 15.5M shares +4.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.4M USD +1200%
Research and Development Expense 131M USD -67.1%
General and Administrative Expense 37M USD -93.1%
Operating Income (Loss) -167M USD +83%
Nonoperating Income (Expense) 3.32M USD -100%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28.7M USD -102%
Income Tax Expense (Benefit) 2K USD 0%
Net Income (Loss) Attributable to Parent -164M USD -110%
Earnings Per Share, Basic -11 USD/shares -101%
Earnings Per Share, Diluted -11 USD/shares -101%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 187M USD -17.8%
Other Assets, Current 283K USD -70.7%
Assets, Current 194M USD -19.9%
Property, Plant and Equipment, Net 4.89M USD -35.8%
Operating Lease, Right-of-Use Asset 6.46M USD +221%
Other Assets, Noncurrent 6.81M USD +0.95%
Assets 212M USD -17.9%
Accounts Payable, Current 8.29M USD -36.3%
Employee-related Liabilities, Current 3.85M USD -14.6%
Accrued Liabilities, Current 28.5M USD +19.4%
Liabilities, Current 38.9M USD -0.29%
Operating Lease, Liability, Noncurrent 5.34M USD
Liabilities 144M USD +268%
Retained Earnings (Accumulated Deficit) -178M USD -1137%
Stockholders' Equity Attributable to Parent 68.6M USD -68.7%
Liabilities and Equity 212M USD -17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.9M USD +43.1%
Net Cash Provided by (Used in) Financing Activities 99.8M USD +158%
Net Cash Provided by (Used in) Investing Activities -21K USD +98.1%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 14.5M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 63.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 187M USD -17.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.3M USD -81.2%
Deferred Tax Assets, Valuation Allowance 21.8M USD -85.1%
Deferred Tax Assets, Gross 24M USD -83.6%
Operating Lease, Liability 7.51M USD +246%
Payments to Acquire Property, Plant, and Equipment 21K USD -98.1%
Lessee, Operating Lease, Liability, to be Paid 8.7M USD +283%
Property, Plant and Equipment, Gross 15.1M USD +0.22%
Operating Lease, Liability, Current 2.17M USD -0.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.94M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 2.86M USD +151%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +24.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.19M USD +1109%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.49M USD
Deferred Tax Assets, Operating Loss Carryforwards 4.73M USD -93.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.49M USD
Additional Paid in Capital 247M USD +5.51%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.79M USD +39.4%
Deferred Tax Assets, Net of Valuation Allowance 2.19M USD +233%
Share-based Payment Arrangement, Expense 1.8M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%